Health Catalyst Drops 20.4% in Four Weeks as EPS Estimates Surge 128%
Health Catalyst shares have dropped 20.4% over the past four weeks, with an RSI reading of 28.93 indicating oversold conditions. Sell-side analysts have boosted the consensus EPS estimate by 128.1% in the last 30 days, and the stock holds a Zacks Rank #2 (Buy).
1. Four-Week 20.4% Stock Decline
Health Catalyst shares have fallen 20.4% over the last four weeks amid heavy selling pressure, pushing the stock significantly below recent trading levels as investors reassess near-term outlooks.
2. RSI at 28.93 Indicates Oversold
The technical Relative Strength Index has dropped to 28.93, a level typically viewed as oversold territory, suggesting that downward momentum may be exhausting and a price rebound could be forthcoming.
3. EPS Estimate Rise 128% and Zacks Rank #2
Sell-side analysts have raised the consensus EPS estimate by 128.1% over the past 30 days, and the stock holds a Zacks Rank #2 (Buy), placing it among the top 20% of ranked equities based on earnings revisions.